Angiocrine Bioscience aims to transform current standards of medical practice by pursuing creative therapies based on its proprietary genetically engineered E-CEL Technology Platform. We have a number of highly differentiated product candidates in our pipeline with a focus on developing best-in-class cellular therapy product opportunities.

Screen Shot 2015-09-04 at 4.50.58 PM